Zhejiang Xianju Pharmaceutical Co Ltd (002332) — Financial Flexibility Index
Zhejiang Xianju Pharmaceutical Co Ltd (002332) has a Financial Flexibility Index of 0.13x as of September 2025. Free cash flow of CN¥160.05 Million (operating CF CN¥130.05 Million minus capex CN¥30.01 Million) represents 0% of total liabilities (CN¥1.24 Billion). Check asset allocation strategy of Zhejiang Xianju Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Xianju Pharmaceutical Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Zhejiang Xianju Pharmaceutical Co Ltd across 20 annual periods. See Zhejiang Xianju Pharmaceutical Co Ltd (002332) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Zhejiang Xianju Pharmaceutical Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Xianju Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Xianju Pharmaceutical Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥456.55 Million | CN¥247.48 Million | CN¥1.18 Billion | ▼ -28.9% |
| 2024 | 0.55x | CN¥606.24 Million | CN¥398.66 Million | CN¥1.11 Billion | ▼ -23.6% |
| 2023 | 0.71x | CN¥830.11 Million | CN¥595.48 Million | CN¥1.16 Billion | ▼ -1.5% |
| 2022 | 0.72x | CN¥891.83 Million | CN¥609.28 Million | CN¥1.23 Billion | ▲ +36.7% |
| 2021 | 0.53x | CN¥942.99 Million | CN¥676.15 Million | CN¥1.78 Billion | ▲ +31.8% |
| 2020 | 0.40x | CN¥907.41 Million | CN¥789.23 Million | CN¥2.26 Billion | ▲ +42.2% |
| 2019 | 0.28x | CN¥782.15 Million | CN¥519.81 Million | CN¥2.77 Billion | ▲ +113.2% |
| 2018 | 0.13x | CN¥362.52 Million | CN¥193.27 Million | CN¥2.73 Billion | ▲ +25.4% |
| 2017 | 0.11x | CN¥290.75 Million | CN¥167.47 Million | CN¥2.75 Billion | ▼ -42.1% |
| 2016 | 0.18x | CN¥253.01 Million | CN¥155.91 Million | CN¥1.38 Billion | ▼ -25.2% |
| 2015 | 0.24x | CN¥314.65 Million | CN¥199.61 Million | CN¥1.29 Billion | ▲ +54.1% |
| 2014 | 0.16x | CN¥249.89 Million | CN¥141.64 Million | CN¥1.57 Billion | ▼ -1.3% |
| 2013 | 0.16x | CN¥252.72 Million | CN¥63.46 Million | CN¥1.57 Billion | ▼ -39.8% |
| 2012 | 0.27x | CN¥331.44 Million | CN¥33.43 Million | CN¥1.24 Billion | ▼ -45.5% |
| 2011 | 0.49x | CN¥421.77 Million | CN¥147.63 Million | CN¥860.02 Million | ▲ +57.9% |
| 2010 | 0.31x | CN¥217.87 Million | CN¥155.29 Million | CN¥701.29 Million | ▲ +63.8% |
| 2009 | 0.19x | CN¥147.62 Million | CN¥104.68 Million | CN¥778.28 Million | ▲ +48.8% |
| 2008 | 0.13x | CN¥95.28 Million | CN¥36.03 Million | CN¥747.44 Million | ▼ -49.9% |
| 2007 | 0.25x | CN¥164.08 Million | CN¥96.53 Million | CN¥644.44 Million | ▲ +68.7% |
| 2006 | 0.15x | CN¥89.56 Million | CN¥53.05 Million | CN¥593.35 Million | — |